Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Items where Year is 2003

Up a level
Export as [feed] RSS
Group by: Creators | Item Type | No Grouping
Jump to: A | B | G | N | S | U | Y
Number of items: 9.

A

Arvidsson, Per I and Ryder, Neil and Weiss, Markus and Gross, Gerhard and Kretz, Olivier and Woessner, Ralph and Seebach, Dieter (2003) Antibiotic and hemolytic activity of a beta2/beta3 peptide capable of folding into a 12/10-helical secondary structure. Chembiochem : a European journal of chemical biology, 4 (12). pp. 1345-1347. ISSN 1439-4227

B

Branford, Susan and Rudzki, Zbigniew and Walsh, Sonya and Parkinson, Ian and Grigg, Andrew and Szer, Jeff and Taylor, Kerry and Herrmann, Richard and Seymour, John F and Arthur, Chris and Joske, David and Lynch, Kevin and Hughes, Tim (2003) Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood, 102 (1). pp. 276-283. ISSN 0006-4971

G

Galanello, Renzo and Piga, Antonio and Alberti, Daniele and Rouan, Marie-Claude and Bigler, Hilde and Séchaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

Galanello, Renzo and Piga, Antonio and Alberti, Daniele Maria and Rouan, Marie-Claude and Bigler, Hilde and Sechaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

Galanello, Renzo and Piga, Antonio and Alberti, Daniele Maria and Rouan, Marie-Claude and Bigler, Hilde and Sechaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

N

Nisbet-Brown, Eric and Olivieri, Nancy F and Giardina, Patricia J and Grady, Robert W and Neufeld, Ellis J and Sechaud, Romain and Krebs-Brown, Axel and Anderson, Judith and Alberti, Daniele Maria and Sizer, Kurt and Nathan, David G (2003) Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet, 361 (9369). pp. 1597-1602. ISSN 0140-6736

S

Skerjanec, Andrej and Berenson, James and Hsu, Chyi-Hung and Major, Pierre and Miller, Wilson H and Ravera, Christina and Schran, Horst and Seaman, John and Waldmeier, Felix (2003) The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function. Journal of clinical pharmacology, 43 (2). pp. 154-162. ISSN 0091-2700

U

Ullman, Brett R and Aja, Teresa and Deckwerth, Thomas L and Diaz, Jose-Luis and Herrmann, Julia and Kalish, Vincent J and Karanewsky, Donald S and Meduna, Steven P and Nalley, Kip and Robinson, Edward D and Roggo, Silvio and Sayers, Robert O and Schmitz, Albert and Ternansky, Robert J and Tomaselli, Kevin J and Wu, Joe C (2003) Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications. Bioorganic & Medicinal Chemistry Letters, 13 (20). pp. 3623-3626. ISSN 0960-894X

Y

Yang, Wei and Kowal, Colleen and Sorensen, Erik and Lassota, Piotr (2003) Genetically modified cancer models: the value of luciferase-tagged tumors and in vivo luciferase-based reporter assays in oncology drug discovery. Breast Cancer Research, 5 (Suppl ). p. 13. ISSN 1465-5411

This list was generated on Mon Dec 9 05:21:48 2019 UTC.

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.